Polymerase Chain Reaction (PCR) Market Set to Reach $18.97 Billion by 2029 with 10.6% Yearly Growth

What Is the Estimated Market Size and Growth Rate for the Polymerase Chain Reaction (PCR) Market?
The market size for polymerase chain reaction (PCR) has seen a robust expansion lately. The sector is anticipated to swell from $11.42 billion in 2024 to $12.67 billion in 2025, expecting an 11.0% compound annual growth rate (CAGR). This surge during the historic timeframe can be linked to a burgeoning number of research institutions, escalating patient count for chronic and infectious diseases, rising cases of genetic and chronic conditions, growing populace, and an increase in the aging population.

In the coming years, the polymerase chain reaction (PCR) market is projected to experience accelerated growth, with estimates suggesting a size of $18.97 billion in 2029, reflecting a compound annual growth rate (CAGR) of 10.6%. Factors contributing to this projected growth during the forecast period include increasing concerns around food safety, rising demands for safe, high-quality food, a surge in the need for molecular diagnostics, the trend towards personalized medicine, and emphasis on digital polymerase chain reaction (dPCR). Noteworthy trends during the forecast years are anticipated to be real-time polymerase chain reaction, DNA sequencing technologies, diagnostic testing improvements, next-generation sequencing (NGS), microfluidics, lab-on-a-chip platforms, and advancements in molecular diagnostic solutions.

What Are the Forces Behind the Rapid Growth of the Polymerase Chain Reaction (PCR) Market?
The expansion of the polymerase chain reaction (PCR) market is likely to be influenced by the growing necessity for customized medication. Personalized or precision medicine is a healthcare strategy that customizes healthcare decisions, practices, interventions, and treatments based on each patient's unique attributes. The need for personalized medicine is rising due to advancements in data analytics, patient-specific treatment outcomes, and the capability to personalize therapies based on personal genetic profiles. PCR assists personalized medicine by enabling the magnification and examination of particular genetic sequences, permitting medical professionals to personalize treatment strategies based on individual genetic profiles. For example, as per the Personalized Medicine Coalition, a professional membership organization based in the US, in 2022, the approval of 12 new personalized medicines constituted roughly 34% of all newly approved therapies, marking a considerable growth from previous years. Hence, the escalating demand for personalized medicine is stimulating the growth of the PCR market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15638&type=smp

Who Are the Dominant Companies Influencing Polymerase Chain Reaction (PCR) Market Trends?
Major companies operating in the polymerase chain reaction (PCR) market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers GmbH, Becton, Dickinson and Company, GE HealthCare Technologies Inc., Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Incorporated, Eurofins Scientific, Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., bioMérieux SA, Beckman Coulter Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., Qiagen N.V., Natera Inc., Myriad Genetics Inc., BGI Genomics Co. Ltd., Cepheid, NeoGenomics Laboratories Inc., 23andMe Holding Co., Ambry Genetics Corporation, Biocartis SA, Centogene N.V., Veritas Genetics

How Is the Polymerase Chain Reaction (PCR) Market Evolving?
The major players in the polymerase chain reaction market are introducing real-time polymerase chain reaction testing kits to enhance precision, productivity, and user-friendliness in genetic analysis. These real-time PCR (RT-PCR) laboratory-produced test kits enable the amplification and quantification of specific DNA sequences in real time. For example, in November 2022, Cepheid, a molecular diagnostics company based in the US, introduced the Xpert Xpress Multiplex Vaginal Panel (MVP). This is an FDA-approved multiplex PCR test capable of identifying DNA from organisms associated with three distinct vaginal infections - bacterial vaginosis (BV), vulvovaginal candidiasis, and trichomoniasis from one vaginal swab sample. Comparatively, it enhances the functionality of conventional polymerase chain reaction techniques by allowing real-time tracking, quantification, and improved sensitivity and specificity, rendering it vital for molecular biology and clinical diagnostics.

What Are the Different Segmentations in the Polymerase Chain Reaction (PCR) Market?
The polymerase chain reaction (PCR) market covered in this report is segmented -

1) By Type: Conventional Polymerase Chain Reaction, Other Types
2) By Indication: Infectious Diseases, Oncology, Genetic Disorders, Other Indications
3) By Application: Medical, Non-Medical
4) By End User: Hospitals And Clinics, Pharmaceutical And Biotechnology Industries, Diagnostic Centers, Academic And Research Organization

Subsegments:
1) By Conventional Polymerase Chain Reaction: Endpoint Pcr, Gel Electrophoresis-Based Pcr, Reverse Transcription Pcr (Rt-Pcr), Quantitative Pcr (Qpcr) For Gene Expression, Nested Pcr
2) By Other Types: Real-Time Pcr (Qpcr) (Quantitative Pcr), Digital Pcr (Dpcr), Multiplex Pcr, Reverse Transcription-Quantitative Pcr (Rt-Qpcr), Isothermal Amplification (Lamp), Next-Generation Pcr (Ngs-Based Pcr Techniques), High-Throughput Pcr

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/polymerase-chain-reaction-pcr-global-market-report

Which Region Is at the Forefront of the Polymerase Chain Reaction (PCR) Market?
North America was the largest region in the polymerase chain reaction (PCR) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the polymerase chain reaction (PCR) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Polymerase Chain Reaction (PCR) Global Market Report?

- Market Size Analysis: Analyze the Polymerase Chain Reaction (PCR) Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Polymerase Chain Reaction (PCR) Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Polymerase Chain Reaction (PCR) Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Polymerase Chain Reaction (PCR) Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15638

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.